Biopharma | May 07, 2026
China poised to launch world’s first CAR-T therapy for gastric cancer
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers
Subscribe To Our Newsletter & Stay Updated
